Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis
- 25 February 2008
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 17 (3), 224-228
- https://doi.org/10.1002/pds.1542
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Lineage-Specific Hematopoietic Growth FactorsNew England Journal of Medicine, 2006
- Population-Based Drug-Induced AgranulocytosisArchives of Internal Medicine, 2005
- Approaches to combat with confounding by indication in observational studies of intended drug effectsPharmacoepidemiology and Drug Safety, 2003
- Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literatureClinical and Laboratory Haematology, 2002
- Acute and chronic neutropenias. What is new?Journal of Internal Medicine, 2001
- Drug-associated blood dyscrasiasAdverse Drug Reaction Bulletin, 2001
- Nonchemotherapy Drug‐Induced Agranulocytosis: A Review of 118 Patients Treated with Colony‐Stimulating FactorsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Granulocyte Colony-Stimulating Factor (G-CSF) Does Not Improve Recovery from Antithyroid Drug-Induced Agranulocytosis: A Prospective StudyThyroid®, 1999
- AgranulocytosisPublished by American Medical Association (AMA) ,1994
- Drug‐induced agranulocytosis: prognostic factors in a series of 168 episodesBritish Journal of Haematology, 1991